Gobi Paramanandam
Gobi Paramanandam publishes mostly in Anesthesiology and Pain Medicine, Oncology and Public Health, Environmental and Occupational Health, on topics such as Pain Management and Opioid Use, Cancer Treatment and Pharmacology and Palliative Care and End-of-Life Issues.
- World rank
- #4,839,309 of 7,710,434 ranked researchers
- Rank in United States
- #1,265,910 of 1,627,098
- Works
- 16
- Citations
- 145
- Citations per work
- 9.1
What does Gobi Paramanandam research?
Gobi Paramanandam's work is mostly in Medicine (57%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences957.4%
- Medicine957.4%
- Everything else636.2%
- Social Sciences16.4%
- 1Anesthesiology and Pain Medicine19% of their works
- 2Oncology15% of their works
- 3Public Health, Environmental and Occupational Health11% of their works
- 4Pediatrics, Perinatology and Child Health6% of their works
- 5Surgery6% of their works
- 6Economics and Econometrics6% of their works
Research topics
- Pain Management and Opioid Use
- Cancer Treatment and Pharmacology
- Palliative Care and End-of-Life Issues
- Pharmacological Effects and Toxicity Studies
- Health Systems, Economic Evaluations, Quality of Life
- Metabolism and Genetic Disorders
- Histone Deacetylase Inhibitors Research
- Biosimilars and Bioanalytical Methods
Which keywords describe Gobi Paramanandam's research?
The keywords of their largest research topics: Quality of Life, Cancer Pain, Pain Management, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, End-of-Life, Palliative Care and Antiepileptic Drugs.
- Immunogenicity
- HDAC Inhibitors
- Biochemical Genetics
- Health Utility Measures
- Antiepileptic Drugs
- End-of-Life
- Chemotherapy-Induced Peripheral Neuropathy
- Cancer Pain
- Quality of Life
- Pain Management
- Taxanes
- Palliative Care
- Cost-effectiveness Analysis
- Prenatal Exposure
- Biosimilars
- Histone Deacetylases
- Metabolic Disorders
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Quality of Life153 topics
- Cancer Pain81 topic
- Pain Management81 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Taxanes51 topic
- End-of-Life31 topic
- Palliative Care31 topic
- Antiepileptic Drugs21 topic
- Cost-effectiveness Analysis21 topic
- Health Utility Measures21 topic
- Prenatal Exposure21 topic
- Biochemical Genetics11 topic
- Biosimilars11 topic
- HDAC Inhibitors11 topic
- Histone Deacetylases11 topic
- Immunogenicity11 topic
- Metabolic Disorders11 topic
Where does Gobi Paramanandam work?
Gobi Paramanandam's main affiliation in the publication record is Center for Pain and the Brain, United States.
How many publications and citations does Gobi Paramanandam have?
OpenAlex counts 16 works and 145 citations for Gobi Paramanandam, an h-index of 3, ranking #4,839,309 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gobi Paramanandam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.